Sebra

Sebra

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sebra (Vante Biopharm) is a specialized medical device manufacturer with a 50+ year history, focusing on RF-based sterile tubing sealers and welders. It serves critical, validation-heavy markets including blood banking and biopharmaceutical single-use manufacturing, where its technology ensures product integrity and sterility. The company operates as part of Machine Solutions Inc., offering both standard equipment and custom-engineered solutions, supported by a strong aftermarket service division. Its recent reacquisition of the SEBRA brand has expanded its product range and reinforced its position in the blood processing industry.

Medical Devices

Technology Platform

Radio Frequency (RF) sealing and welding technology for creating sterile, hermetic seals in medical-grade thermoplastic tubing (PVC, EVA, TPE). The platform includes validated sealing parameters and supports portable, benchtop, and custom system configurations.

Opportunities

The global shift towards single-use systems in biopharmaceutical manufacturing represents a major growth driver, creating sustained demand for validated sterile connection equipment.
Furthermore, the stable, high-volume needs of the global blood and plasma collection industry provide a reliable core market with recurring revenue from consumables and service.

Risk Factors

Key risks include technological disruption from alternative sterile connection methods or new tubing materials, dependence on validation-heavy markets where regulatory changes can be costly, and competitive pressure from larger life science tool companies.
Supply chain vulnerabilities for specialized components also pose an operational risk.

Competitive Landscape

Sebra/Vante competes in specialized niches against other focused medical tubing sealer manufacturers. They face potential competition from large, diversified life science capital equipment suppliers that could enter the market. Their competitive edge lies in deep material expertise, validated processes, a long industry track record, and a dual-brand strategy covering both blood banking and biopharma.